Black Diamond

Trident Enterprises Leaps Over Digital Hurdles with Bridgeline’s Advanced Search Solutions

Retrieved on: 
Thursday, September 21, 2023
Trident, Diamond, Natural language processing, Partnership, Black Diamond, BigCommerce, E-commerce, SKU, Face, Digital, Berlin Packaging, Online shopping

WOBURN, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a leader in cloud-based marketing technology software, announced today that Trident Enterprises, a leading livestock fencing supplier, has selected Bridgeline's powerful search solution to grow online revenue by enhancing their online search.

Key Points: 
  • WOBURN, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a leader in cloud-based marketing technology software, announced today that Trident Enterprises, a leading livestock fencing supplier, has selected Bridgeline's powerful search solution to grow online revenue by enhancing their online search.
  • This initiative will focus on two of Trident's e-commerce sites: Easy Pet Fence Store and Deer Busters, accessible via www.easypetfence.com and www.deerbusters.com respectively.
  • Trident selected HawkSearch for their site on BigCommerce grow eCommerce sales through search results that drive traffic and improve user experience.
  • Ari Kahn, CEO of Bridgeline Digital, commented, “This partnership echoes Bridgeline's dedication to excellence for online user experiences.

Lactalis Canada Invests in New Distribution Centre in Oshawa, Ontario

Retrieved on: 
Tuesday, September 19, 2023
Diamond, Carbon, Workforce, Partnership, Balderson, Senior, Astro, GTA, Black Diamond, Cheese, Architecture, Snow, Lactalis, Cracker Barrel, Supply chain, Listed buildings in England, Growth, Warehouse, Renewable energy, Broccolini

TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Lactalis Canada Inc. (‘Lactalis Canada’) – the Canadian dairy leader behind iconic brands such as Cracker Barrel, Black Diamond, Balderson, Astro and Lactantia and a subsidiary of France-based Lactalis Group – today announced that it is entering into a long-term lease for a new distribution centre located in Oshawa, Ontario, principally for its cheese and tablespreads supply chain network.

Key Points: 
  • TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Lactalis Canada Inc. (‘Lactalis Canada’) – the Canadian dairy leader behind iconic brands such as Cracker Barrel, Black Diamond, Balderson, Astro and Lactantia and a subsidiary of France-based Lactalis Group – today announced that it is entering into a long-term lease for a new distribution centre located in Oshawa, Ontario, principally for its cheese and tablespreads supply chain network.
  • Set to open in Q4 2024, the agreement was facilitated by CBRE Limited and the distribution centre will be developed, built, and leased by Broccolini with construction beginning immediately.
  • “Lactalis Canada’s new facility in Oshawa will become the largest distribution centre, from a capacity standpoint, for Lactalis Group globally,” said Mark Taylor, President & CEO, Lactalis Canada.
  • Source of energy will be fully on the Ontario power grid with no additional reliance on non-renewable energy sources.

Black Diamond Therapeutics Announces CEO Transition

Retrieved on: 
Monday, September 18, 2023
Diamond, Yale New Haven Hospital, Gilead Sciences, Yale University, Executive, Senior, G1 Therapeutics, ARCH Venture Partners, Senior advisor, Food and Drug Administration, Cancer, Black Diamond, Washington University in St. Louis, Gilead, Patient, Chairperson, Drug discovery, Faculty, Growth, CGI, FDA, Leukemia, IND, Food, Corporate development, Pharmaceutical industry, Nursing, G1

CAMBRIDGE, Mass. and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families of oncogenic mutations in patients with genetically defined cancers, announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been appointed as Chief Executive Officer (CEO) effective immediately. Dr. Velleca succeeds Company CEO and co-founder, David M. Epstein, Ph.D., who has stepped down and will continue to serve on the Board of Directors of the Company.

Key Points: 
  • and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families of oncogenic mutations in patients with genetically defined cancers, announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been appointed as Chief Executive Officer (CEO) effective immediately.
  • Dr. Velleca succeeds Company CEO and co-founder, David M. Epstein, Ph.D., who has stepped down and will continue to serve on the Board of Directors of the Company.
  • Prior to joining the Black Diamond Board, Dr. Velleca served as CEO of G1 Therapeutics, Inc. (Nasdaq: GTHX).
  • Most recently, Dr. Velleca was CEO of StrideBio, a gene therapy company, and a Venture Partner at Hatteras Venture Partners.

Black Diamond Co-Founder Jim Walker Rejoins Black Diamond Capital Management as President and Senior Managing Director

Retrieved on: 
Thursday, September 14, 2023
Diamond, Housing, Dennert Fir Tree, Fir Tree, Black Diamond, Head, Walker, Free Enterprise Fund v. Public Company Accounting Oversight Board, Vulnerability and Risk Committee, LP, Risk management, L.L.C

With 30 years of experience in asset management, Walker is a proven leader and was most recently a managing partner of Fir Tree Partners, a global investment firm.

Key Points: 
  • With 30 years of experience in asset management, Walker is a proven leader and was most recently a managing partner of Fir Tree Partners, a global investment firm.
  • At Fir Tree, Jim was responsible for overall firm management, identifying new areas of investment opportunity, growing the firm's global LP group and building a team of talented leaders.
  • "As we build out our leadership team, I am excited to have Jim return to Black Diamond.
  • Jim co-founded Black Diamond with Steve Deckoff in 1995 and was integrally involved in the firm's early investment funds.

Black Diamond Group Announces Ranking on the 2023 TSX30 List

Retrieved on: 
Tuesday, September 12, 2023
Diamond, Workforce, BDI, Toronto Stock Exchange, Black Diamond, TSX, Growth, Ecosystem, Management

CALGARY, Alberta, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the "Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, is proud to have secured a spot on the 2023 TSX30 List.

Key Points: 
  • CALGARY, Alberta, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the "Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, is proud to have secured a spot on the 2023 TSX30 List.
  • Over the past three years, Black Diamond has achieved remarkable growth, with a 304% increase in dividend-adjusted share price performance and a 327% increase in market capitalization over the same period.
  • "The 2023 TSX30 features strong Canadian representation, including Black Diamond Group Limited, which is headquartered in Alberta," remarked Loui Anastasopoulos, CEO of the Toronto Stock Exchange.
  • "We are proud to celebrate the tremendous success and expansion of Black Diamond Group, and we want to congratulate all of the TSX30 companies for their tremendous growth."

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Retrieved on: 
Tuesday, September 5, 2023
Diamond, Morgan Stanley, Pharming, Black Diamond, M26 Modular Accessory Shotgun System, Patient, Cancer, Webcast, Morgan, Conference, Pharmaceutical industry

and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today announced that company management will participate in three upcoming investor conferences:

Key Points: 
  • and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today announced that company management will participate in three upcoming investor conferences:
    The 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, in Boston, MA.
  • The Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023.
  • Black Diamond President and Chief Executive Officer, David M. Epstein, Ph.D. will participate in a fireside chat at 3:35 p.m.
  • Black Diamond Chief Business Officer and Chief Financial Officer, Fang Ni, Pharm.D.

Suede dominates the 2023 Aranya Xiami Music Festival, rocking the Aranya Beach for three days

Retrieved on: 
Monday, September 4, 2023
Tao, Diamond, Music, Travel, Food, Blue Foundation, Freedom, PAN, Alibaba Pictures, Analgesic, Life, Nova Heart, Mosaic Music Festival, Suede, Black Diamond, Yell, Another Life, Emotion, Element, MONO, Another Day Another Life, Fin, Traveler, Wind, Sunrise Sessions, All Tomorrow's Parties (2009 film), Music festival, City, System, Tao Piao Piao, Female, Theatre, Film industry, Entertainment, Nightclub, Aranya

One particularly noteworthy addition to the 2023 Aranya Xiami Music Festival was the introduction of the unique "Sunrise Session" special project.

Key Points: 
  • One particularly noteworthy addition to the 2023 Aranya Xiami Music Festival was the introduction of the unique "Sunrise Session" special project.
  • The Aranya Xiami Music Festival's distinctive music presentation and format has garnered significant popularity among young attendees.
  • Innovative multi-scene approach and expression of lifestyle brought differentiated experience, earning praise from music enthusiasts
    The 2023 Aranya Xiami Music Festival focused on creating unforgettable experiences, establishing itself as a landmark vacation music festival.
  • In terms of user experience, this year's Aranya Xiami Music Festival has introduced many innovations.

Black Diamond Group Limited Releases 2023 Corporate Responsibility Report

Retrieved on: 
Thursday, August 31, 2023
Diamond, Social responsibility, Workforce, BDI, Corporate social responsibility, Culture, Black Diamond, Social Security Government Pension Offset, Sustainability accounting, Sustainability Accounting Standards Board, Corporation, TSX, Growth, ESG, Social, Environment, Safety, Management

CALGARY, Alberta, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the "Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, today released its 2023 Corporate Responsibility Report.

Key Points: 
  • CALGARY, Alberta, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the "Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, today released its 2023 Corporate Responsibility Report.
  • “As we publish our 2023 Corporate Responsibility Report, during our 20th year in business I am proud of the legacy we have built as a Company,” said Trevor Haynes, Chairman & CEO.
  • Black Diamond’s Corporate Responsibility Report is guided by The Sustainability Accounting Standards Board, or SASB, Standards and Black Diamond is most appropriately situated within the Engineering & Construction Services Industry.
  • To view Black Diamond’s Corporate Responsibility Report, visit this link: https://www.blackdiamondgroup.com/responsibility/

Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Friday, August 11, 2023
Diamond, FGFR, MAP, Myenteric plexus, DNA, AACR, Central nervous system, PRS, GBM, Diarrhea, RECIST, Clinical trial, Cancer, MAPK, Black Diamond, BRAF, Mutation, TKI, G&A, Toxicity, Appetite, Lung cancer, Paronychia, CNS, Rash, Glioblastoma, II, M26 Modular Accessory Shotgun System, Development, State Administrative Expenses, RAS, Patient, Investment, EGFR, Stomatitis, Administration, Drug discovery, Nausea, Neoplasm, Poster, R, Research, FDA, Therapy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, III, ORR, Food, Safety, Fatigue, RAF, Medical imaging, Pharmaceutical industry, Security (finance), Life insurance, NSCLC

and NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today reported financial results for the second quarter ended June 30, 2023, and provided a corporate update.

Key Points: 
  • and NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today reported financial results for the second quarter ended June 30, 2023, and provided a corporate update.
  • Black Diamond initiated a Phase 1 clinical trial for BDTX-4933 in select indications for patients harboring all-class BRAF or RAS mutations in the second quarter of 2023.
  • Net cash used in operations was $14.4 million for the second quarter of 2023 compared to $18.1 million for the second quarter of 2022.
  • Black Diamond ended the second quarter of 2023 with approximately $89.5 million in cash, cash equivalents and investments.

Clarus Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 7, 2023
Diamond, Adventure, Capital expenditure, NOL, Gateway Group, Weakness, Black Diamond, CLAR, Internal Revenue Code, Public expenditure, EBITDA, Corporation, Euro, Collection, Risk, Internal Revenue Code section 1031, Capital, Outdoor, Payment card, Retail, Pharmaceutical industry, Video game

Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, reported financial results for the second quarter ended June 30, 2023.
  • “Our second quarter results were impacted by the continued challenging macroeconomic environment and related headwinds,” said Warren Kanders, Clarus’ Executive Chairman.
  • Capital expenditures in the second quarter of 2023 were $1.8 million compared to $2.2 million in the prior year quarter.
  • The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its second quarter 2023 results.